However, chemerin is downregulated in most tumor tissues, including melanoma, acute myeloid leukemia, breast cancer, and adrenocortical carcinoma 152, indicating that chemerin downregulation can induce tumor immune escape. Here, RARRES2 is linked to breast carcinoma.